Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Operating Income (2016 - 2025)

Historic Operating Income for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$275000.0.

  • CV Sciences' Operating Income rose 1935.48% to -$275000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year increase of 5721.33%. This contributed to the annual value of -$2.2 million for FY2024, which is 16517.86% down from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Operating Income is -$275000.0, which was up 1935.48% from -$131000.0 recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Operating Income peaked at $5.8 million during Q1 2023, and registered a low of -$8.8 million during Q4 2021.
  • For the 5-year period, CV Sciences' Operating Income averaged around -$1.3 million, with its median value being -$889000.0 (2023).
  • In the last 5 years, CV Sciences' Operating Income skyrocketed by 48033.0% in 2023 and then plummeted by 11076.02% in 2024.
  • Quarter analysis of 5 years shows CV Sciences' Operating Income stood at -$8.8 million in 2021, then skyrocketed by 75.97% to -$2.1 million in 2022, then skyrocketed by 58.16% to -$889000.0 in 2023, then grew by 27.33% to -$646000.0 in 2024, then soared by 57.43% to -$275000.0 in 2025.
  • Its Operating Income was -$275000.0 in Q3 2025, compared to -$131000.0 in Q2 2025 and $11000.0 in Q1 2025.